Dr. Agarwal's Eye [DRAGARWQ] vs KMC Speciality [KMCSHIL] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr. Agarwal's Eye Hospital Ltd. wins in 9 metrics, KMC Speciality Hospitals India Limited wins in 10 metrics, with 0 ties. KMC Speciality Hospitals India Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dr. Agarwal's Eye Hospital Ltd. KMC Speciality Hospitals India Limited Better
P/E Ratio (TTM) 34.01 40.06 Dr. Agarwal's Eye Hospital Ltd.
Price-to-Book Ratio 7.52 8.09 Dr. Agarwal's Eye Hospital Ltd.
Debt-to-Equity Ratio 106.45 47.30 KMC Speciality Hospitals India Limited
PEG Ratio 1.81 0.48 KMC Speciality Hospitals India Limited
EV/EBITDA 20.64 19.02 KMC Speciality Hospitals India Limited
Profit Margin (TTM) 15.50% 12.88% Dr. Agarwal's Eye Hospital Ltd.
Operating Margin (TTM) 19.54% 23.66% KMC Speciality Hospitals India Limited
EBITDA Margin (TTM) 19.54% 23.66% KMC Speciality Hospitals India Limited
Return on Equity 26.07% 13.04% Dr. Agarwal's Eye Hospital Ltd.
Return on Assets (TTM) 8.91% 7.49% Dr. Agarwal's Eye Hospital Ltd.
Free Cash Flow (TTM) $-83.80M $-62.99M KMC Speciality Hospitals India Limited
Dividend Yield 0.11% N/A N/A
1-Year Return 12.35% 75.08% KMC Speciality Hospitals India Limited
Price-to-Sales Ratio (TTM) 5.39 5.14 KMC Speciality Hospitals India Limited
Enterprise Value $26.69B $15.31B Dr. Agarwal's Eye Hospital Ltd.
EV/Revenue Ratio 5.92 5.38 KMC Speciality Hospitals India Limited
Gross Profit Margin (TTM) 78.09% 86.05% KMC Speciality Hospitals India Limited
Revenue per Share (TTM) $952 $17 Dr. Agarwal's Eye Hospital Ltd.
Earnings per Share (Diluted) $147.68 $2.24 Dr. Agarwal's Eye Hospital Ltd.
Beta (Stock Volatility) -0.57 -0.13 Dr. Agarwal's Eye Hospital Ltd.

Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dr. Agarwal's Eye Hospital Ltd.0.58%0.12%-1.62%6.94%-8.52%-6.31%
KMC Speciality Hospitals India Limited0.51%5.86%25.78%46.86%57.94%48.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dr. Agarwal's Eye Hospital Ltd.12.35%240.02%1,131.89%2,480.68%5,282.48%17,498.05%
KMC Speciality Hospitals India Limited75.08%79.95%209.93%1,499.87%6,792.44%34,767.65%

Performance & Financial Health Analysis: Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited

MetricDRAGARWQKMCSHIL
Market Information
Market Cap i₹24.28B₹14.64B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,25680,768
90 Day Avg. Volume i1,37866,406
Last Close₹4,991.20₹119.15
52 Week Range₹4,142.00 - ₹6,392.00₹62.50 - ₹124.85
% from 52W High-21.91%-4.57%
All-Time High₹7,300.00 (Dec 30, 2024)₹124.85 (Jun 03, 2026)
% from All-Time High-31.63%-4.57%
Growth Metrics
Quarterly Revenue Growth0.22%0.34%
Quarterly Earnings Growth0.66%0.83%
Financial Health
Profit Margin (TTM) i0.16%0.13%
Operating Margin (TTM) i0.20%0.24%
Return on Equity (TTM) i0.26%0.13%
Debt to Equity (MRQ) i106.4547.30
Cash & Liquidity
Book Value per Share (MRQ)₹668.22₹11.09
Cash per Share (MRQ)₹191.98₹1.82
Operating Cash Flow (TTM) i₹738.70M₹362.55M
Levered Free Cash Flow (TTM) i₹546.50M₹214.27M
Dividends
Last 12-Month Dividend Yield i0.11%N/A
Last 12-Month Dividend i₹5.00N/A

Valuation & Enterprise Metrics Analysis: Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited

MetricDRAGARWQ (Apr 26, 2026)KMCSHIL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i34.0140.06
Forward P/E i516.77N/A
PEG Ratio i1.810.48
Price to Sales (TTM) i5.395.14
Price to Book (MRQ) i7.528.09
Market Capitalization
Market Capitalization i₹24.28B₹14.64B
Enterprise Value i₹26.69B₹15.31B
Enterprise Value Metrics
Enterprise to Revenue i5.925.38
Enterprise to EBITDA i20.6419.02
Risk & Other Metrics
Beta i-0.57-0.13
Book Value per Share (MRQ) i₹668.22₹11.09

Financial Statements Comparison: Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDRAGARWQ (2025)KMCSHIL (2025)
Revenue/Sales i3.94B2.29B
Cost of Goods Sold i896.20M336.77M
COGS % of Revenue i22.8%14.7%
Gross Profit i3.04B1.96B
Gross Margin i77.2%85.3%
Research & Development iN/AN/A
Operating Income (EBIT) i813.30M386.65M
Operating Margin i20.6%16.9%
EBITDA i1.22B600.92M
EBITDA Margin i31.1%26.2%
Pre-Tax Income i707.00M316.03M
Pre-Tax Income % of Revenue i17.9%13.8%
Income Tax i160.50M101.76M
Income Tax % of Revenue i4.1%4.4%
Net Income (Profit) i546.50M214.27M
Profit Margin i13.9%9.3%

Balance Sheet & Liquidity Metrics

MetricDRAGARWQ (2025)KMCSHIL (2025)
Cash & Equivalents i111.60M91.90M
Total Current Assets i559.40M332.41M
Total Current Assets % of Revenue i14.2%14.5%
Total Current Liabilities i869.80M379.41M
Total Current Liabilities % of Revenue i22.1%16.5%
Long-Term Debt i3.06B778.48M
Long-Term Debt % of Revenue i77.6%33.9%
Total Shareholders Equity i2.10B1.64B
Retained Earnings i1.99B1.50B
Retained Earnings % of Revenue i50.4%65.3%
Property, Plant & Equipment i1.37B976.56M

Cash Flow Statement Comparison

MetricDRAGARWQ (2025)KMCSHIL (2025)
Operating Cash Flow i738.70M362.55M
Operating Cash Flow % of Revenue i18.8%15.8%
Capital Expenditures i4.10M-638.72M
Free Cash Flow i-83.80M-62.99M
FCF Margin i-2.1%-2.7%
Debt Repayment i-111.30M-91.57M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDRAGARWQKMCSHIL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i4.83M163.09M
Float Shares i1.08M36.79M
% Held by Insiders i77.59%77.49%
% Held by Institutions i3.57%0.00%
% Held by Public i18.84%22.51%

Dividend Analysis & Yield Comparison: Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited

MetricDRAGARWQKMCSHIL
Last 12-Month Dividend i₹5.00N/A
Last 12-Month Dividend Yield i0.11%N/A
3-Year Avg Annual Dividend i₹4.50N/A
3-Year Avg Dividend Yield i0.12%N/A
3-Year Total Dividends i₹13.50N/A
Ex-Dividend DateNov 08, 2024N/A